Abstract:
Partial peptide mimetics and methods of making and using, wherein the partial peptide mimetics have a first amino acid sequence comprising ANIKLSVQMKL (SEQ ID NO: 8), a homolog thereof, or a segment of SEQ ID NO: 8 or a homolog thereof, a second amino acid sequence comprising IIVKLND (SEQ ID NO:2), a homolog thereof, or a segment of SEQ ID NO:2 or a homolog thereof, and a β -turn inducing scaffold bonded between the first and second amino acid sequences.
Abstract:
Topomimetic calixarene-based peptide mimetics with cytotoxic tumoricidal activity are described. Methods of use and methods of designing such calixarene-based peptide mimetics are described.
Abstract:
A method of preparing a korupensamine or an analog thereof comprising: (a) reacting a compound of formula (III), wherein each of R and R is CH3 or H, X is I, Y is (C1-C4)alkyl, benzyl or CHO, and each of R and R is (C1-C4)alkyl, benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group; with a compound of formula (IV), wherein R is benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group, R is B(OH)2, and R is (C1-C4)alkyl; in the presence of a Pd(0) catalyst and an inorganic base in an organic solvent, to yield a compound of formula (V), wherein Y, R , R , R , R , R and R are as defined above for compounds of formula (III) and (IV). Additionally the intermediates of formula (III), wherein X is Br, Cl or I, Y is H, (C1-C4)alkyl, benzyl, or CHO, each of R and R 3 is a protecting group selected from the group consisting of (C1-C4)alkyl, benzyl, (C2-C5)acyl and an acid-labile hydroxy protecting group; and R is H or (C2-C5)acyl; or wherein X is Br, Cl or I, Y is H, (C1-C4)alkyl, benzyl, or CHO, each of R and R is H or CH5, R is H or (C2-C5)acyl and R is a protecting group selected from the group consisting of (C1-C4)alkyl, benzyl, (C2-C5)acyl and an acid-labile hydroxy protecting group; and the intermediates of formula (IV), wherein R is Cl, Br, I, B(OH)2, an anhydride or ester of B(OH)2, or OSO2R , wherein R is (C1-C4)perfluoroalkyl, and each of R and R is H, (C1-C4)alkyl, benzyl, (C2-C5)acyl or an acid-labile hydroxy protecting group.
Abstract:
Disclosed herein are novel compounds. Such compounds may be synthesized using a hexadehydro-Diels- Alder (HDD A) reaction. Also disclosed are organic devices including one or more disclosed compounds. The organic devices can include organic electronic devices, organic photonic devices, or combinations thereof. Specific types of devices can include, for example, organic light-emitting diodes (OLEDs), organic photovoltaic (OPV) devices, organic field-effect transistors (OFETs), or combinations thereof.
Abstract:
A class of topomimetic calixarene-based peptide mimetics is described. Calixarene-based peptide mimetics have various biological activities such as, for example, bactericidal activity, antiangiogenic activity, and/or antitumor activity. Methods of use and methods of designing calixarene-based peptide mimetics are described.
Abstract:
Partial peptide mimetics and methods of making and using, wherein the partial peptide mimetics have a first amino acid sequence comprising ANIKLSVQMKL (SEQ ID NO: 8), a homolog thereof, or a segment of SEQ ID NO: 8 or a homolog thereof, a second amino acid sequence comprising IIVKLND (SEQ ID NO:2), a homolog thereof, or a segment of SEQ ID NO:2 or a homolog thereof, and a β-turn inducing scaffold bonded between the first and second amino acid sequences.
Abstract:
A class of topomimetic calixarene-based peptide mimetics is described. Calixarene-based peptide mimetics have various biological activities such as, for example, bactericidal activity, antiangiogenic activity, and/or antitumor activity. Methods of use and methods of designing calixarene-based peptide mimetics are described.
Abstract:
A class of topomimetic calixarene-based peptide mimetics is described. Calixarene-based peptide mimetics have various biological activities such as, for example, bactericidal activity, antiangiogenic activity, and/or antitumor activity. Methods of use and methods of designing calixarene-based peptide mimetics are described.